在结直肠癌辅助疗法中的活性氧物种
Yang Zhang1, Mengqiu Hao2, Xuyang Yang1
1Colorectal Cancer Center and Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China; Research Laboratory of Tumor Epigenetics and Genomics, Department of General Surgery, Frontiers Science Center for Disease-related Molecular Network and National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
反应性氧物种 (ROS) 显著影响结直肠癌 (CRC) 辅助疗法. 操纵ROS显示了提高CRC患者治疗疗效的潜力.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 结肠直肠癌 (CRC) 是一个主要的全球健康问题,需要辅助疗法,如化疗和免疫疗法.
- 反应性氧物种 (ROS) 在CRC进展,向疗法的有效性和耐药性方面发挥着关键作用.
研究的目的:
- 综合当前关于ROS在CRC辅助疗法的作用的研究.
- 探索ROS影响CRC治疗结果的机制.
主要方法:
- 在CRC辅助疗法中调查ROS的研究的综合文献综述.
- 分析ROS介导的机制,包括细胞死亡,增殖,DNA损伤,新陈代谢和血管生成.
主要成果:
- ROS影响CRC辅助治疗的多个方面,包括细胞存活,增殖和DNA完整性.
- ROS调制与克服药物耐药性和增强治疗反应有关.
- 早期的临床试验表明,ROS操纵策略可以改善CRC辅助治疗结果.
结论:
- 反应性氧物种 (ROS) 是结直肠癌 (CRC) 辅助疗法的有效性的一个关键因素.
- 向ROS为改善治疗结果和克服CRC管理中的抵抗提供了一个有希望的策略.
相关概念视频
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs for Treatment of Ulcerative Colitis in IBD
Oxygen Requirements and Growth Patterns


